Ezz Life Science Holdings Ltd. · ASX:EZZ
Ezz Life Science — H1 2021 Earnings Presentation
11 slides from Ezz Life Science's earnings presentation, Apr 14, 2021
Slide 1: 1H FY21 Results Presentation
For personal use only 1H FY21 Results Presentation 14 April 2021
Slide 2: Disclaimer
Disclaimer This document has been prepared by EZZ Life Science Holdings Limited ACN 608 363 604 (Company). By accepting a copy of this document you warrant and undertake to the Company that For personal use only you agree to be bound by the terms and conditions set out below. This document is not a
Slide 3: Table of Contents
Table of Contents Chapter Topic Page For personal use only 1 Company Overview 1 2 Key Highlights 2 3 Financial Performance 3 4 Segment & Geographic Performance 4 5 Margin & Customer Profile Improvements 5 6 Strategic Focus 6 7 Outlook 7 8 Outlook 8
Slide 4: Company Overview
1 Company Overview Company Background Company History Share Information For personal use only Operation: July 2018 104 Derby Street, Started operating as a Silverwater, NSW 2128, wholesale distributor of Australia the EAORON branded products Brands & Products: July 2020 Became an exclusive distribut
Slide 5: Key Highlights
2 Key Highlights For personal use only 1H FY21 Performance 2H FY21 Operational 5-Year Strategic Plan on Track Outlook Launched Demonstrated agility through the 1H FY21 with Selected products under the EZZ brand are A clear strategic road map for the immediate and double-digit revenue growth desp
Slide 6: Financial Performance
3 Financial Performance For personal use only Revenue EBIT NPAT Net profit margin $12.6M $1.7M $1.2M 9.7% +38.6% from 1H FY20 +213.6% from 1H FY20 +228.6% from 1H FY20 +137.1% from 1H FY20 Page 3
Slide 7: Segment & Geographic Performance
4 Segment & Geographic Performance Revenue by Segment Revenue by Geography For personal use only $ 9.1 M $ 9.1 M $ 7.0 M $ 6.9 M $ 5.5 M $ 5.7 M $ 0.0 M $ 0.0 M 1H FY20 1H FY21 1H FY20 1H FY21 Australia & New Zealand China Other International Consumer health Skin care Page 4
Slide 8: Margin & Customer Profile Improvements
5 Margin & Customer Profile Improvements Gross Profit Margin Customer Profile For personal use only FY20 1H FY21 86.3% 87.0% 10.8% 9.8% 6.1% 8.7% 58.4% 6.6% 7.0% 7.2% 56.3% 6.7% 62.7% 5.2% 23.1% 13.1% 20.3% 22.1% FY20 1H FY21 Top 1 Customer Top 2 Customer Top 3 Customer Top 4 Customer Top 5 Customer
Slide 9: Strategic Focus
6 Strategic Focus 2 2 3 3 For personal use only Brands Segments Platforms Markets Consumer Health Retailers Core range 960 distribution points Immunity as of 31 Dec 2020 Longevity support Probiotics Growth support E-commerce Basic range 1H FY21 conversion rate on Tmall Global: 2.2% - 5.3% Skin manag
Slide 10: Outlook
7 Outlook For personal use only Resilient 2H FY21 Growth Momentum Improved FY21 Performance to Continue in FY21 Margin The 2H FY21 performance is expected to show Subject to market conditions, the demand for skin Subject to market conditions, the revenue resilience, with the impact of the prolonged
Slide 11: For personal use only
Ajuo sn peuosied 104 EZZ
EZZ Life Science Holdings — H1 2021 Earnings Presentation on 6ix